
Phase 1 driving simulation finds bedtime GlyphAllo for major depressive disorder shows no next-morning driving impairment, while advancing allopregnanolone-based oral treatment development.
Psychiatry experts explain why off-label psych meds and polypharmacy can be essential.
Joseph F. Goldberg, MD, sat down with Henry Nasrallah, MD, to discuss the essentials of off-label prescribing and uses of




